Anti-HMGB1 antibody reduces weight gain in mice fed a high-fat diet

Nutrition and Diabetes

Volumn 5, Issue , 2015, Pages

  Montes, V N ^a   Subramanian, S ^a   Goodspeed, L ^a   Wang, S A ^a   Omer, M ^a   Bobik, A ^b   Teshigawara, K ^c   Nishibori, M ^c   Chait, A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HIGH MOBILITY GROUP B1 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; GENE EXPRESSION; GLUCOSE TOLERANCE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 84935894752     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2015.11     Document Type: Article

References (18)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
2. Cildir G, Akincilar SC, Tergaonkar V. Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol Med 2013; 19: 487-500.
3. McNelis JC, Olefsky JM. Macrophages, Immunity, and Metabolic Disease. Immunity 2014; 41: 36-48.
4. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343: 1467-1476.
5. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (∗). Annu Rev Immunol 2009; 27: 165-197.
6. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002; 72: 1084-1091.
7. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28: 367-388.
8. Wang H, Li W, Goldstein R, Tracey KJ, Sama AE. HMGB1 as a potential therapeutic target. Novartis Found Symp 2007; 280: 73-85 discussion 85-91, 160-4.
9. Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004; 24: 2320-2325.
10. Kanellakis P, Agrotis A, Kyaw TS, Koulis C, Ahrens I, Mori S et al. High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2011; 31: 313-319.
11. Morton GJ, Kaiyala KJ, Fisher JD, Ogimoto K, Schwartz MW, Wisse BE. Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. Am J Physiol Endocrinol Metab 2011; 300: E392-E401.
12. Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 2002; 282: E207-E214.
13. Lewis KE, Kirk EA, McDonald TO, Wang S, Wight TN, O'Brien KD et al. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation 2004; 110: 540-545.
14. Montes VN, Turner MS, Subramanian S, Ding Y, Hayden-Ledbetter M, Slater S et al. T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice. PLoS ONE 2013; 8: e67709.
15. Subramanian S, Han CY, Chiba T, McMillen TS, Wang SA, Haw A 3rd et al. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28: 685-691.
16. O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K et al. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25: 785-790.
17. den Hartigh LJ, Wang S, Goodspeed L, Ding Y, Averill M, Subramanian S et al. Deletion of serum amyloid a3 improves high fat high sucrose diet-induced adipose tissue inflammation and hyperlipidemia in female mice. PLoS ONE 2014; 9: e108564.
18. Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 2012; 32: 1771-1776.